Publicacións (25) Publicacións de Alberto Cordero

2024

  1. Lipoprotein(a) and Long-Term Recurrent Infarction After an Acute Myocardial Infarction

    American Journal of Cardiology, Vol. 211, pp. 9-16

2023

  1. Patients With High Cardiovascular Risk as Candidates to Bempedoic Acid, After Treatment With Statins, Ezetimibe and PCSK9 Inhibitors: An Estimation and Cost-Effectiveness Analysis

    Journal of cardiovascular pharmacology, Vol. 81, Núm. 1, pp. 70-75

2022

  1. Current trends on antithrombotic therapy

    REC: CardioClinics

  2. Early angiography in elderly patients with non-ST-segment elevation acute coronary syndrome: The cardio CHUS-HUSJ registry

    International Journal of Cardiology, Vol. 351, pp. 8-14

  3. Myocarditis after RNA-based vaccines for coronavirus.

    International Journal of Cardiology, Vol. 353, pp. 131-134

2021

  1. Comorbidity burden and revascularization benefit in elderly patients with acute coronary syndrome

    Revista Espanola de Cardiologia, Vol. 74, Núm. 9, pp. 765-772

  2. Impact of comorbidities in the decision of using invasive management in elderly patients with NSTEACS

    REC: Interventional Cardiology, Vol. 3, Núm. 1, pp. 15-20

  3. Long term prognostic benefit of complete revascularization in elderly presenting with NSTEMI: Real world evidence

    Reviews in Cardiovascular Medicine, Vol. 22, Núm. 2, pp. 475-482

  4. Managing NSTEMI in older patients

    The Lancet

  5. Mortality associated with cardiovascular disease in patients with COVID-19

    REC: CardioClinics, Vol. 56, Núm. 1, pp. 30-38

  6. Multicenter and all-comers validation of a score to select patients for manual thrombectomy, the DDTA score

    Catheterization and Cardiovascular Interventions, Vol. 98, Núm. 3, pp. E342-E350

  7. New-onset heart failure after acute coronary syndrome in patients without heart failure or left ventricular dysfunction

    Revista Espanola de Cardiologia, Vol. 74, Núm. 6, pp. 494-501

  8. Prognostic benefit from an early invasive strategy in patients with non-ST elevation acute coronary syndrome (NSTEACS): evaluation of the new risk stratification in the NSTEACS European guidelines

    Clinical Research in Cardiology, Vol. 110, Núm. 9, pp. 1464-1472

  9. Removal of the intermediate risk group in the latest European guidelines for NSTEACS: is it justified?

    Revista Espanola de Cardiologia, Vol. 74, Núm. 10, pp. 891-893

  10. Sex differences in the management of patients with acute coronary syndrome: A population-based ecological cross-sectional study in Spain

    REC: CardioClinics, Vol. 56, Núm. 3, pp. 168-178

  11. Soluble ST2 and Diuretic Efficiency in Acute Heart Failure and Concomitant Renal Dysfunction

    Journal of Cardiac Failure, Vol. 27, Núm. 4, pp. 427-434

2020

  1. A simple score to select patients for manual thrombectomy in emergent percutaneous coronary interventions: The DDTA score

    Journal of Cardiovascular Medicine, Vol. 21, Núm. 8, pp. 595-602

  2. Cardiovascular complications and prognosis in COVID-19 patients

    Revista Espanola de Cardiologia Suplementos, Vol. 20, Núm. SE, pp. 9-13

  3. Effect of insulin on readmission for heart failure following a hospitalization for acute heart failure

    ESC Heart Failure, Vol. 7, Núm. 6, pp. 3320-3328

  4. Prevention of myocardial infarction and stroke with PCSK9 inhibitors treatment: a metanalysis of recent randomized clinical trials

    Journal of Diabetes and Metabolic Disorders, Vol. 19, Núm. 2, pp. 759-765